Veeva Systems Stock News

Veeva Systems (NYSE:VEEV) was downgraded by Morgan Stanley from an overweight rating to an equal weight rating in a report released on Thursday, The Fly reports. A number of other equities analysts have also recently commented on the company. SVB Leerink reduced their price target on Veeva Systems from $296.00 to $282.00 and set a []

Wall Street brokerages expect Veeva Systems Inc. (NYSE:VEEV) to report sales of $480.37 million for the current quarter, Zacks reports. Seven analysts have provided estimates for Veeva Systems earnings. The lowest sales estimate is $478.87 million and the highest is $487.80 million. Veeva Systems posted sales of $396.76 million during the same quarter last year, []

Chicago Capital LLC lowered its stake in shares of Veeva Systems Inc. (NYSE:VEEV) by 0.9% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 155,368 shares of the technology company’s stock after selling 1,343 shares during the period. Veeva Systems comprises about 1.7% of […]

Adoption of Veeva Systems' (VEEV) cloud applications is likely to significantly boost its Commercial Cloud business.

Insights into the full patient journey will speed the path to diagnosis for niche patient populations Veeva Systems announced that PharmaEssentia has adopted Veeva Data Cloud to support the launch of BESREMi, a new therapy approved for adults with polycythemia vera (PV), a rare blood cancer. Veeva Longitudinal Patient Data will provide essential insights to help the company reach hard-to-find patient populations [] The post PharmaEssentia USA Corporation Selects Veeva Data Cloud To Support Launch Of Novel Therapy For Rare, Chronic Blood Cancer appeared first on AiThority .

Veeva Systems (NYSE:VEEV) had its price target cut by Citigroup from $356.00 to $349.00 in a research note issued on Monday, The Fly reports. The firm presently has a buy rating on the technology companys stock. Citigroups target price indicates a potential upside of 33.21% from the companys previous close. A number of other research []

Investors continue to be optimistic about Veeva Systems (VEEV) owing to its strong product portfolio.

A latest research report by ResearchMoz states that the Global Healthcare CRM (Customer Relationship Management) Market will grow at rapid pace and account for around XX Bn during the forecast period of 2021 to 2027. The report gives detailed data on

Baldwin Brothers LLC MA decreased its position in shares of Veeva Systems Inc. (NYSE:VEEV) by 37.5% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 500 shares of the technology company’s stock after selling 300 shares during the period. Baldwin Brothers LLC MA’s holdings […]

Veeva Systems' (VEEV) Veracity Logic buyout can help companies to simplify complex processes and speed up clinical trials.

Assenagon Asset Management S.A. acquired a new position in Veeva Systems Inc. (NYSE:VEEV) in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 2,019 shares of the technology companys stock, valued at approximately $582,000. Other large investors have also modified their []

Veeva Systems (NYSE: VEEV) recently announced it has acquired Veracity Logic. These are the details.

Related Stocks: TSCO , SIVB , ARE , JLL , VEEV , CMG , IT , WCN , ZS , DDOG , PCTY , LNG , TWLO , COUP , FIVN , Z , TXRH , SAM ,

Veeva Systems (NYSE:VEEV) issued an update on its fourth quarter 2022 earnings guidance on Wednesday morning. The company provided earnings per share guidance of $0.880-$0.880 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.860. The company issued revenue guidance of $478 million-$480 million, compared to the consensus revenue estimate []